MBA-m1
Based on 1 Customer Validation
MBA-m1 is a reversible non-covalent allosteric inhibitor of mMLKL2, with a Kd value of 6 μM for mMLKL2. MBA-m1 delays Necroptosis. MBA-m1 has no effect on the activities of RIPK1 or RIPK3. MBA-m1 alleviates skin injury, epidermal thickening and immune cell infiltration in dermatitis models, and reduces aortic diameter enlargement and structural changes in abdominal aortic aneurysm models. MBA-m1 can be used in research related to dermatitis and abdominal aortic aneurysm.
For research use only. We do not sell to patients.
- Purity : 96.37%
- CAS No.: 305866-70-0
- Formula: C27H21ClN2O2
- Molecular Weight:440.92
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Huh-7 | CC50 |
7.07 μM
Compound: GNF-Pf-2622
|
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
|
[PMID: 18579783] |
| SK-BR-3 | IC50 |
5 μM
Compound: 33
|
Cytotoxicity against human SKBr3 cells after 72 hrs by MTT assay
Cytotoxicity against human SKBr3 cells after 72 hrs by MTT assay
|
[PMID: 18500794] |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:wild-type and MLKL knockout NIH-3T3 cells
-
Concentration:5, 10 μM
-
Incubation Time:0-24 h (post-TS treatment)
-
Result:Had no discernible effect on the kinetics of RIPK1-mediated extrinsic apoptosis in either wild-type or MLKL knockout NIH-3T3 cells.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6N mice (30-40 days old)[1]
-
Dosage:30 mg/kg
-
Administration:i.p.; every other day; 21 days
-
Result:Significantly ameliorated dermatitis with patches of healthy and moderately inflamed dorsal skin.
Reduced epidermal thickness compared to vehicle controls.
Decreased CD45-positive cell infiltration in both healthy and inflamed tissue compared to vehicle controls.
Lowered dermatitis severity scores at study endpoint compared to vehicle controls.
Chemical Information
-
CAS No. 305866-70-0
-
Appearance Solid
-
Molecular Weight 440.92
-
Formula C27H21ClN2O2
-
Color White to off-white
-
SMILES
ClC1=CC(NC2=CC(C)=NC3=C2C=C(OC)C=C3)=CC=C1OC4=CC5=C(C=CC=C5)C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)